| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Caris Life Sciences, Inc.
13G/A
Amendment 2
CAI · 142152107
|
4.0% |
8/12/2026
Event 6/30/2026
|
|||
| J H Whitney VI L P | 4.0% | ||||
| J. H. Whitney Equity Partners VI, LLC | 4.0% | ||||
| Vigano Paul R | 4.0% | ||||
| Williams Robert M Jr | 4.0% | ||||
|
Caris Life Sciences, Inc.
13G/A
Amendment 1
CAI · 142152107
|
6.5% |
5/12/2026
Event 3/31/2026
|
|||
| J H Whitney VI L P | 6.5% | ||||
| J. H. Whitney Equity Partners VI, LLC | 6.5% | ||||
| Vigano Paul R | 6.5% | ||||
| Williams Robert M Jr | 6.5% | ||||
|
Caris Life Sciences, Inc.
13G
CAI · 142152107
|
7.3% |
8/14/2025
Event 6/30/2025
|
|||
| J H Whitney VI LP | 7.3% | ||||
| J. H. Whitney Equity Partners VI, LLC | 7.3% | ||||
| Vigano Paul R | 7.3% | ||||
| Williams Robert M Jr | 7.3% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.